Last reviewed · How we verify
Ovide (malathion) lotion 0.05%
Ovide (malathion) lotion works by killing lice and their eggs on the scalp.
Ovide (malathion) lotion works by killing lice and their eggs on the scalp. Used for Treatment of head lice infestations.
At a glance
| Generic name | Ovide (malathion) lotion 0.05% |
|---|---|
| Sponsor | Sun Pharmaceutical Industries, Inc. |
| Drug class | insecticide |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
Malathion is an organophosphate insecticide that acts as a cholinesterase inhibitor, disrupting the nervous system of lice and ultimately leading to their death. It also has ovicidal properties, killing lice eggs on the scalp.
Approved indications
- Treatment of head lice infestations
Common side effects
- Skin irritation
- Dandruff
- Itching
Key clinical trials
- Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice (PHASE1)
- Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ovide (malathion) lotion 0.05% CI brief — competitive landscape report
- Ovide (malathion) lotion 0.05% updates RSS · CI watch RSS
- Sun Pharmaceutical Industries, Inc. portfolio CI